CAS 168273-06-1
:Rimonabant
Description:
Rimonabant, with the CAS number 168273-06-1, is a selective cannabinoid receptor antagonist primarily known for its role in weight management and obesity treatment. It acts by blocking the CB1 receptors in the central nervous system, which are involved in appetite regulation and energy balance. This compound is characterized by its chemical formula C22H21Cl3N2O, and it features a complex structure that includes a tricyclic core. Rimonabant was initially marketed as an anti-obesity drug but was withdrawn from the market due to concerns about psychiatric side effects, including depression and anxiety. Its pharmacological profile also suggests potential applications in metabolic disorders, but the adverse effects have limited its use. Rimonabant is typically administered orally and has a relatively long half-life, allowing for once-daily dosing. Despite its withdrawal, research continues into its mechanisms and potential therapeutic uses, particularly in understanding the endocannabinoid system's role in various physiological processes.
Formula:C22H21Cl3N4O
InChI:InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)
InChI key:InChIKey=JZCPYUJPEARBJL-UHFFFAOYSA-N
SMILES:CC1=C(N(N=C1C(NN2CCCCC2)=O)C3=C(Cl)C=C(Cl)C=C3)C4=CC=C(Cl)C=C4
Synonyms:- 1-(2,4-Dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
- 1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-
- 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid N-(piperidin-1-yl)amide
- 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide
- 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide
- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide hydrochloride (1:1)
- A 281
- Acomplia
- Enp 9
- N-Piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide
- Rimonabant(Acomplia,Sr141716)
- Sr 141617
- Sr 141716
- Zimulti
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Rimonabant
CAS:<p>Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1.</p>Formula:C22H21Cl3N4OPurity:98% - 99.91%Color and Shape:White Or Almost White Crystalline PowderMolecular weight:463.795-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide
CAS:Formula:C22H21Cl3N4OPurity:98%Color and Shape:SolidMolecular weight:463.7873Rimonabant base
CAS:Formula:C22H21Cl3N4OPurity:≥ 98%Color and Shape:White to off-white powder or crystalsMolecular weight:463.79Rimonabant
CAS:Formula:C22H21Cl3N4OPurity:>98.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:463.79Rimonabant
CAS:Controlled Product<p>Cannabinoid receptor 1 (CB1) antagonist. Lowers consumption of food, via central and peripheral mechanisms. Reduces triglyceride and low-density lipoprotein levels (LDLs). Reduces nicotine dependence, potentially by modulating dopaminergic signalling. Serious adverse effects associated with Rimonabant include psychiatric disorders such as anxiety and depression.</p>Formula:C22H21Cl3N4OColor and Shape:PowderMolecular weight:463.79 g/molRimonabant - Bio-X ™
CAS:Controlled Product<p>Rimonabant is cannabinoid receptor type 1 (CB1) inverse agonist drug. Rimonabant is used to treat obesity by reducing appetite and calorie intake. It lowers the consumption of food, via central and peripheral mechanisms. It also reduces triglyceride and low-density lipoprotein levels (LDLs). This drug has shown to reduce nicotine dependence, potentially by modulating dopaminergic signalling. ></p>Formula:C22H21Cl3N4OPurity:Min. 99.0%Color and Shape:PowderMolecular weight:463.79 g/mol




